Myriam Maoz

Author PubWeight™ 11.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples. Int J Cancer 2005 1.20
2 Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation. FASEB J 2003 1.14
3 Human protease-activated receptor 1 expression in malignant epithelia: a role in invasiveness. Arterioscler Thromb Vasc Biol 2003 1.02
4 Protease-activated receptor-1 (hPar1), a survival factor eliciting tumor progression. Mol Cancer Res 2007 1.01
5 Transcriptional regulation of human protease-activated receptor 1: a role for the early growth response-1 protein in prostate cancer. Cancer Res 2007 0.95
6 Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization. Cancer Res 2006 0.91
7 PAR1 plays a role in epithelial malignancies: transcriptional regulation and novel signaling pathway. IUBMB Life 2011 0.91
8 Protease activated receptor-1, PAR1, promotes placenta trophoblast invasion and beta-catenin stabilization. J Cell Physiol 2009 0.87
9 Etk/Bmx regulates proteinase-activated-receptor1 (PAR1) in breast cancer invasion: signaling partners, hierarchy and physiological significance. PLoS One 2010 0.86
10 Protease-activated receptor-1 (PAR1) acts via a novel Galpha13-dishevelled axis to stabilize beta-catenin levels. J Biol Chem 2010 0.84
11 Identification of a novel functional androgen response element within hPar1 promoter: implications to prostate cancer progression. FASEB J 2005 0.81
12 DVL as a scaffold protein capturing classical GPCRs. Commun Integr Biol 2010 0.75
13 Par genes: molecular probes to pathological assessment in breast cancer progression. Patholog Res Int 2011 0.75